Login/Sign Up
Mimcipar 30mg Tablet 10's belongs to the class of medications called 'calcimimetics' used to treat primary hyperparathyroidism, secondary hyperparathyroidism, and parathyroid-carcinoma. Primary hyperparathyroidism is a condition in which one or more parathyroid glands make too much parathyroid hormone (PTH). Secondary hyperparathyroidism is the medical condition of excessive secretion of parathyroid hormone (PTH) by the parathyroid glands in response to hypocalcemia (low blood calcium levels), with resultant hyperplasia (increase in the number of cells) of these glands. Parathyroid cancer is a rare disease in which malignant (cancer) cells form in a parathyroid gland's tissues.
Mimcipar 30mg Tablet 10's contains 'cinacalcet', which works by signalling the body to produce a less parathyroid hormone to decrease the amount of calcium in the blood.
In some cases, Mimcipar 30mg Tablet 10's may cause common side effects like vomiting, nausea, rash, headache, muscle pain, and diarrhoea. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, consult a doctor.
Do not take Mimcipar 30mg Tablet 10's if you are allergic to ‘cinacalcet’ or other ingredients. Inform your doctor if you are taking any other medicines other than Mimcipar 30mg Tablet 10's. Before taking Mimcipar 30mg Tablet 10's, inform your doctor if you have chronic kidney disease, gastrointestinal bleeding, heart failure, liver diseases, or cardiac arrhythmia. Mimcipar 30mg Tablet 10's is not recommended in hypotension and hypocalcemia. Consult your doctor if you are pregnant or breastfeeding.
Mimcipar 30mg Tablet 10's contains 'cinacalcet', which belongs to the class of medications called 'calcimimetics' used in the treatment of primary hyperparathyroidism, secondary hyperparathyroidism, and parathyroid-carcinoma. It works by signalling the body to produce less parathyroid hormone to decrease the amount of calcium in the blood.
Do not take Mimcipar 30mg Tablet 10's if you are allergic to any of its ingredients. Inform your doctor if you are taking medicines other than Mimcipar 30mg Tablet 10's. Before taking Mimcipar 30mg Tablet 10's, inform your doctor if you have chronic kidney disease, gastrointestinal bleeding, heart failure, liver diseases, adynamic bone disease, or cardiac arrhythmia. Consult your doctor if you are pregnant or breastfeeding. Before taking Mimcipar 30mg Tablet 10's, inform your doctor if you have rare hereditary problems of galactose intolerance.
Drug-Drug Interactions: Mimcipar 30mg Tablet 10's may interact with antifungal drugs (ketoconazole and itraconazole), antacids (Balofloxacin), anti-depressant (amitryptiline, amoxapine, pimozide, thioridazine, fluvoxamine, imipramine), a protease inhibitor (indinavir, ritonavir), antibiotics (clarithromycin, erythromycin), hormonal drugs (tamoxifen), antiarrhythmics (flecainide, carvedilol, verapamil), anti-cancer (vinblastine), anti-TB (rifampicin).
Drug-Food Interactions: Do not take grapefruit or grapefruit juice while using Mimcipar 30mg Tablet 10's.
Drug-Disease Interactions: Mimcipar 30mg Tablet 10's should be used with caution in patients with chronic kidney disease, gastrointestinal bleeding, heart failure, liver diseases, adynamic bone disease, cardiac arrhythmia, hypotension, hypocalcemia, or galactose intolerance.
Hyperparathyroidism: Hyperparathyroidism is a condition in which one or more of your parathyroid glands become overactive and release (secrete) too much parathyroid hormone (PTH). This causes the levels of calcium in your blood to rise, a condition known as hypercalcemia. There are two types of hyperparathyroidism, primary and secondary.
Primary hyperparathyroidism: Primary hyperparathyroidism is a condition in which one or more parathyroid glands make too much parathyroid hormone (PTH). This can lead to the loss of bone tissue. Symptoms include constipation, frequent urination, increased thirst, joint pain, kidney pain (due to kidney stones), loss of appetite, and muscle weakness.
Secondary hyperparathyroidism: Secondary hyperparathyroidism is the medical condition of excessive secretion of parathyroid hormone (PTH) by the parathyroid glands in response to hypocalcemia (low blood calcium levels), with resultant hyperplasia (increase in the number of cells) of these glands. This disorder is primarily seen in patients with chronic kidney failure. Symptoms include muscle pain and weakness.
Parathyroid cancer: Parathyroid cancer is a rare disease in which malignant (cancer) cells form in a parathyroid gland's tissues. Symptoms include weakness, tiredness, nausea, vomiting, loss of appetite, weight loss for no known reason, being much more thirsty than usual, urinating much more than usual, and constipation.
About Mimcipar 30mg Tablet 10's
Mimcipar 30mg Tablet 10's belongs to the class of medications called 'calcimimetics' used to treat primary hyperparathyroidism, secondary hyperparathyroidism, and parathyroid-carcinoma. Primary hyperparathyroidism is a condition in which one or more parathyroid glands make too much parathyroid hormone (PTH). Secondary hyperparathyroidism is the medical condition of excessive secretion of parathyroid hormone (PTH) by the parathyroid glands in response to hypocalcemia (low blood calcium levels), with resultant hyperplasia (increase in the number of cells) of these glands. Parathyroid cancer is a rare disease in which malignant (cancer) cells form in a parathyroid gland's tissues.
Mimcipar 30mg Tablet 10's contains 'cinacalcet', which works by signalling the body to produce a less parathyroid hormone to decrease the amount of calcium in the blood.
In some cases, Mimcipar 30mg Tablet 10's may cause common side effects like vomiting, nausea, rash, headache, muscle pain, and diarrhoea. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, consult a doctor.
Do not take Mimcipar 30mg Tablet 10's if you are allergic to ‘cinacalcet’ or other ingredients. Inform your doctor if you are taking any other medicines other than Mimcipar 30mg Tablet 10's. Before taking Mimcipar 30mg Tablet 10's, inform your doctor if you have chronic kidney disease, gastrointestinal bleeding, heart failure, liver diseases, or cardiac arrhythmia. Mimcipar 30mg Tablet 10's is not recommended in hypotension and hypocalcemia. Consult your doctor if you are pregnant or breastfeeding.
₹5772.8*
MRP ₹7040
18% off
₹5984*
MRP ₹7040
15% CB
₹1056 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Product Substitutes
Uses of Mimcipar 30mg Tablet 10's
Medicinal Benefits
Mimcipar 30mg Tablet 10's contains 'cinacalcet', which belongs to the class of medications called 'calcimimetics' used in the treatment of primary hyperparathyroidism, secondary hyperparathyroidism, and parathyroid-carcinoma. It works by signalling the body to produce less parathyroid hormone to decrease the amount of calcium in the blood.
Side Effects of Mimcipar 30mg Tablet 10's
Directions for Use
Storage
Drug Warnings
Do not take Mimcipar 30mg Tablet 10's if you are allergic to any of its ingredients. Inform your doctor if you are taking medicines other than Mimcipar 30mg Tablet 10's. Before taking Mimcipar 30mg Tablet 10's, inform your doctor if you have chronic kidney disease, gastrointestinal bleeding, heart failure, liver diseases, adynamic bone disease, or cardiac arrhythmia. Consult your doctor if you are pregnant or breastfeeding. Before taking Mimcipar 30mg Tablet 10's, inform your doctor if you have rare hereditary problems of galactose intolerance.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Hyperparathyroidism: Hyperparathyroidism is a condition in which one or more of your parathyroid glands become overactive and release (secrete) too much parathyroid hormone (PTH). This causes the levels of calcium in your blood to rise, a condition known as hypercalcemia. There are two types of hyperparathyroidism, primary and secondary.
Primary hyperparathyroidism: Primary hyperparathyroidism is a condition in which one or more parathyroid glands make too much parathyroid hormone (PTH). This can lead to the loss of bone tissue. Symptoms include constipation, frequent urination, increased thirst, joint pain, kidney pain (due to kidney stones), loss of appetite, and muscle weakness.
Secondary hyperparathyroidism: Secondary hyperparathyroidism is the medical condition of excessive secretion of parathyroid hormone (PTH) by the parathyroid glands in response to hypocalcemia (low blood calcium levels), with resultant hyperplasia (increase in the number of cells) of these glands. This disorder is primarily seen in patients with chronic kidney failure. Symptoms include muscle pain and weakness.
Parathyroid cancer: Parathyroid cancer is a rare disease in which malignant (cancer) cells form in a parathyroid gland's tissues. Symptoms include weakness, tiredness, nausea, vomiting, loss of appetite, weight loss for no known reason, being much more thirsty than usual, urinating much more than usual, and constipation.